Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock, par value $0.00001 per share
-
Shares outstanding
-
96,015,846
-
Total 13F shares
-
36,440,182
-
Share change
-
+11,787,882
-
Total reported value
-
$470,450,874
-
Put/Call ratio
-
37%
-
Price per share
-
$12.91
-
Number of holders
-
84
-
Value change
-
+$156,067,581
-
Number of buys
-
58
-
Number of sells
-
30
Institutional Holders of Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share (CABA) as of Q2 2023
As of 30 Jun 2023,
Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share (CABA) was held by
84 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
36,440,182 shares.
The largest 10 holders included
FRED ALGER MANAGEMENT, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., COMMODORE CAPITAL LP, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Cormorant Asset Management, LP, Lynx1 Capital Management LP, Bain Capital Life Sciences Investors, LLC, VR Adviser, LLC, VANGUARD GROUP INC, and BlackRock Inc..
This page lists
84
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.